New insights on oxidative stress in the artery wall

被引:145
作者
Stocker, R [1 ]
Keaney, JF
机构
[1] Univ New S Wales, Sch Med Sci, Ctr Vasc Res, Sydney, NSW 2052, Australia
[2] Boston Univ, Med Ctr, Dept Med, Whitaker Cardiovasc Inst, Boston, MA USA
关键词
antioxidants; atherosclerosis; cardiovascular disease; inflammation; oxidative stress;
D O I
10.1111/j.1538-7836.2005.01370.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis and its resultant cardiovascular events represent a state of heightened oxidative stress that is commonly thought to contribute to atherogenesis. The aim of this review is to summarize the data linking oxidative events to the pathogenesis of atherosclerosis. Despite abundant data supporting the presence of lipid and protein oxidation in the vascular wall, the poor performance of antioxidant strategies in limiting either atherosclerosis or cardiovascular events from atherosclerosis remain a fundamental problem for implicating oxidative stress as pathophysiologically important. Direct evidence that oxidative stress in general, and the oxidative modification of low-density lipoprotein in particular, is both necessary and sufficient for atherosclerosis has been difficult to find. There are many potential reasons for this difficulty, not the least of which is our lack of sufficient knowledge delineating the precise molecular events that beget oxidative stress in the vessel wall, and the precise mediators involved. Further investigation elucidating these oxidative events are required to provide us with the tools to limit oxidative stress at its source and ameliorate all of its secondary phenomena. Only then will we know what components of atherosclerosis are directly due to oxidative stress.
引用
收藏
页码:1825 / 1834
页数:10
相关论文
共 96 条
[31]   3-chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima [J].
Hazen, SL ;
Heinecke, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09) :2075-2081
[32]   Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions [J].
Hazen, SL ;
Gaut, JP ;
Crowley, JR ;
Hsu, FF ;
Heinecke, JW .
BIOCHEMICAL JOURNAL, 2000, 352 :693-699
[33]   Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall [J].
Heinecke, JW .
FASEB JOURNAL, 1999, 13 (10) :1113-1120
[34]   p-Hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima [J].
Heller, JI ;
Crowley, JR ;
Hazen, SL ;
Salvay, DM ;
Wagner, P ;
Pennathur, S ;
Heinecke, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :9957-9962
[35]   ENHANCED MACROPHAGE DEGRADATION OF LOW-DENSITY LIPOPROTEIN PREVIOUSLY INCUBATED WITH CULTURED ENDOTHELIAL-CELLS - RECOGNITION BY RECEPTORS FOR ACETYLATED LOW-DENSITY LIPOPROTEINS [J].
HENRIKSEN, T ;
MAHONEY, EM ;
STEINBERG, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (10) :6499-6503
[36]  
Heydeck D, 2001, J LIPID RES, V42, P1082
[37]  
Hink U, 2001, CIRC RES, V88, pE14
[38]   Vascular effects following homozygous disruption of p47phox -: An essential component of NADPH oxidase [J].
Hsich, E ;
Segal, BH ;
Pagano, PJ ;
Rey, FE ;
Paigen, B ;
Deleonardis, J ;
Hoyt, RF ;
Holland, SM ;
Finkel, T .
CIRCULATION, 2000, 101 (11) :1234-1236
[39]  
Hwang SJ, 1997, CIRCULATION, V96, P4219
[40]   Obesity and systemic oxidative stress - Clinical correlates of oxidative stress in the Framingham Study [J].
Keaney, JF ;
Larson, MG ;
Vasan, RS ;
Wilson, PWF ;
Lipinska, I ;
Corey, D ;
Massaro, JM ;
Sutherland, P ;
Vita, JA ;
Benjamin, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (03) :434-439